Lind Kevin Robert has filed 3 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 1370 shares of Avalo Therapeutics, Inc. ($AVTX) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Avalo Therapeutics, Inc. | $AVTX | Lind Kevin Robert | Not found | A | Stock Option (Right to Buy) | 1370 | $12.13 | 1,370.0000 | 18,133,968 | 9999.99% | 0.01% |
| Dec. 31, 2025 | Avalo Therapeutics, Inc. | $AVTX | Lind Kevin Robert | Director | A | Stock Option (Right to Buy) | 848 | $14.74 | 848.0000 | 18,133,968 | 9999.99% | 0.00% |
| Oct. 1, 2025 | Avalo Therapeutics, Inc. | $AVTX | Lind Kevin Robert | Director | A | Stock Option (Right to Buy) | 40200 | $0.00 | 40,200.0000 | 10,671,934 | 9999.99% | 0.38% |